Clinical Trial Update: RELIEF-PD: Crisugabalin for Nociplastic Pain in Parkinson's Disease [Phase 4]

View source ↗

Summary

The document announces a Phase 4 clinical trial (RELIEF-PD) evaluating crisugabalin for nociplastic pain in Parkinson's disease, with status currently not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Crisugabalin (crisugabalin)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Parkinson's Disease With Nociceptive Pain | Phase 4 | Status: ACTIVE_NOT_RECRUITING